Avalo Therapeutics Files 8-K
Ticker: AVTX · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1534120
| Field | Detail |
|---|---|
| Company | Avalo Therapeutics, INC. (AVTX) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing
Related Tickers: AVTX
TL;DR
AVTX filed an 8-K, looks like standard reporting, no major news.
AI Summary
Avalo Therapeutics, Inc. filed an 8-K on June 20, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events, financial figures, or material changes beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates routine corporate reporting by Avalo Therapeutics, Inc. without disclosing new material events.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain information that suggests an immediate change in risk for investors.
Key Numbers
- 001-37590 — SEC File Number (Identifies the company's filing with the SEC.)
- 45-0705648 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Avalo Therapeutics, Inc. (company) — Registrant
- June 20, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 1500 Liberty Ridge Drive, Suite 321, Wayne, Pennsylvania 19087 (address) — Principal executive offices
- Cerecor Inc. (company) — Former company name
FAQ
What specific 'Other Events' are being reported by Avalo Therapeutics, Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but does not specify the nature of these events within the provided text.
Does this 8-K filing disclose any new financial statements or exhibits beyond routine reporting?
The filing lists 'Financial Statements and Exhibits' as an item information, but the provided text does not detail the content of these exhibits.
What is the former name of Avalo Therapeutics, Inc.?
The former name of Avalo Therapeutics, Inc. was Cerecor Inc., with a date of name change on November 2, 2011.
Where are Avalo Therapeutics, Inc.'s principal executive offices located?
Avalo Therapeutics, Inc.'s principal executive offices are located at 1500 Liberty Ridge Drive, Suite 321, Wayne, Pennsylvania 19087.
What is the SIC code for Avalo Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Avalo Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Avalo Therapeutics, Inc. (AVTX).